...
首页> 外文期刊>Biochimica et biophysica acta. Bioenergetics >Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation
【24h】

Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation

机译:减少VDAC1表达诱导癌细胞凋亡中促凋亡蛋白的非凋亡作用

获取原文
获取原文并翻译 | 示例
           

摘要

Proteins initially identified as essential for apoptosis also mediate a wide range of non-apoptotic functions that include cell cycle progression, differentiation and metabolism. As this phenomenon was mostly reported with non-cancer cells, we considered non-conventional roles for the apoptotic machinery in the cancer setting. We found that treating glioblastoma (GBM) tumors with siRNA against VDAC1, a mitochondrial protein found at the crossroads of metabolic and survival pathways and involved in apoptosis, inhibited tumor growth while leading to differentiation of tumor cells into neuronal-like cells, as reflected in the expression of specific markers. Although VDAC1 depletion did not induce apoptosis, the expression levels of several pro-apoptotic regulatory proteins were changed. Specifically, VDAC1 deletion led to up-regulation of caspases, p53, cytochrome c, and down-regulation of SMAC/Diablo, AIF and TSPO. The down-regulated group was highly expressed in U-87MG xenografts, as well as in GBMs from human patients. We also showed that the rewired cancer-cell metabolism resulting from VDAC1 depletion reinforced cell growth arrest and differentiation via alterations in the transcription factors p53, c-Myc, HIF-1 alpha and NF-kappa B. The decrease in c-Myc, HIF-1 alpha and NF-kappa B levels was in accord with reduced cell proliferation, whereas increased p53 expression promoted differentiation. Thus, upon metabolic re-programing induced by VDAC1 depletion, the levels of pro-apoptotic proteins associated with cell growth decreased, while those connected to cell differentiation increased, converting GBM cells into astrocyte- and neuron like cells. The results reveal that in tumors, pro-apoptotic proteins can perform non-apoptotic functions, acting as regulators of cell growth and differentiation, making these molecules potential new targets for cancer therapy. This article is part of a Special Issue entitled 'EBEC 2016: 19th European Bioenergetics Conference, Riva del Garda, Italy, July 2-6, 2016', edited by Prof. Paolo Bernardi. (C) 2016 Elsevier B.V. All rights reserved.
机译:最初被鉴定为细胞凋亡必不可少的蛋白质还介导了广泛的非凋亡功能,包括细胞周期进程,分化和代谢。由于这种现象主要是由非癌细胞引起的,因此我们认为凋亡机制在癌症环境中具有非常规作用。我们发现用针对VDAC1的siRNA来治疗胶质母细胞瘤(GBM)肿瘤是一种线粒体蛋白,它在代谢和生存途径的十字路口被发现并参与凋亡,抑制了肿瘤的生长,同时导致肿瘤细胞分化为神经元样细胞。特定标记的表达。尽管VDAC1耗竭不会诱导细胞凋亡,但几种促凋亡调控蛋白的表达水平却发生了变化。具体而言,VDAC1缺失导致胱冬酶,p53,细胞色素c上调,以及SMAC / Diablo,AIF和TSPO的下调。下调的组在U-87MG异种移植以及人类患者的GBM中高度表达。我们还显示,VDAC1耗竭导致的重新连接的癌细胞代谢通过转录因子p53,c-Myc,HIF-1 alpha和NF-κB的变化增强了细胞的生长停滞和分化。 -1α和NF-κB水平与细胞增殖减少一致,而p53表达增加则促进分化。因此,在由VDAC1耗尽引起的代谢重编程后,与细胞生长相关的促凋亡蛋白水平降低,而与细胞分化相关的蛋白水平升高,从而将GBM细胞转化为星形胶质细胞和神经元样细胞。结果表明,在肿瘤中,促凋亡蛋白可以执行非凋亡功能,充当细胞生长和分化的调节剂,使这些分子成为癌症治疗的新靶标。本文是由Paolo Bernardi教授编辑的题为“ EBEC 2016:第19届欧洲生物能学会议,意大利里瓦德尔加尔达,2016年7月2日至2016年”的特刊的一部分。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号